SOLIGENIX, INC. Capital Expenditures
SOLIGENIX, INC. (SNGX) reported Capital Expenditures of $5.88 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- SOLIGENIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.96K.
- SOLIGENIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $608.00.
- SOLIGENIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- SOLIGENIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2015-09-30 was $8.39K.
- SOLIGENIX, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $5.88K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.96K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.57K derived: sum of 2 quarters · filed 2026-03-31 | $5.88K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $608.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.92K 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $3.31K 10-Q · filed 2026-08-07 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $7.16K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $7.16K 10-Q · filed 2016-08-11 | |||
| 2015-09-30 | $8.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $22.10K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $13.71K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |